AstraZeneca plc[1] (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993.[2][3] The Company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Contents |
|